Benitec Biopharma (BNTC) Operating Income (2019 - 2025)
Historic Operating Income for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to -$9.8 million.
- Benitec Biopharma's Operating Income fell 7725.31% to -$9.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$41.8 million, marking a year-over-year decrease of 8570.48%. This contributed to the annual value of -$41.8 million for FY2025, which is 8570.48% down from last year.
- According to the latest figures from Q2 2025, Benitec Biopharma's Operating Income is -$9.8 million, which was down 7725.31% from -$15.3 million recorded in Q1 2025.
- Over the past 5 years, Benitec Biopharma's Operating Income peaked at -$3.5 million during Q1 2022, and registered a low of -$15.3 million during Q1 2025.
- In the last 5 years, Benitec Biopharma's Operating Income had a median value of -$4.8 million in 2021 and averaged -$6.0 million.
- Its Operating Income has fluctuated over the past 5 years, first surged by 877.93% in 2022, then plummeted by 27032.12% in 2025.
- Over the past 5 years, Benitec Biopharma's Operating Income (Quarter) stood at -$4.8 million in 2021, then decreased by 16.03% to -$5.6 million in 2022, then decreased by 23.48% to -$6.9 million in 2023, then tumbled by 55.98% to -$10.8 million in 2024, then increased by 8.99% to -$9.8 million in 2025.
- Its Operating Income was -$9.8 million in Q2 2025, compared to -$15.3 million in Q1 2025 and -$10.8 million in Q4 2024.